SEARCH

SEARCH BY CITATION

References

  • 1
    Berrino F,Sant M,Verdecchia A,Capocaccia R,Hakulinen T,Estève J. Survival of cancer patients in Europe: the EUROCARE study. Lyon: International Agency for Research on Cancer, 1995.
  • 2
    Berrino F,Capocaccia R,Estève J,Gatta G,Hakulinen T,Micheli M,Sant M,Verdecchia A. Survival of cancer patients in Europe: the EUROCARE-2 study. Lyon: International Agency for Research on Cancer, 1999.
  • 3
    Berrino F,Capocaccia R,Coleman MP,Estève J,Gatta G,Hakulinen T,Micheli M,Sant M,Verdecchia A. Survival of cancer patients in Europe: the EUROCARE-3 study. Ann Oncol 2003; 14 ( Suppl 5): v1v155.
  • 4
    Berrino F,De AR,Sant M,Rosso S,Bielska-Lasota M,Coebergh JW,Santaquilani M. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study. Lancet Oncol 2007; 8: 77383.
  • 5
    Yu XQ,O'Connell DL,Forman D. Comparison of cancer survival in UK and Australia: rates are higher in Australia for three major sites. Br J Cancer 2004; 91: 16635.
  • 6
    Coleman MP,Babb P,Damiecki P,Grosclaude P,Honjo S,Jones J,Knerer G,Pitard A,Quinn MJ,Sloggett A,De Stavola BL. Cancer survival trends in England and Wales 1971–1995: deprivation and NHS region. Series SMPS No. 61. London: The Stationery Office, 1999.
  • 7
    Coleman MP,Rachet B,Woods LM,Mitry E,Riga M,Cooper N,Quinn MJ,Brenner H,Estève J. Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001. Br J Cancer 2004; 90: 136773.
  • 8
    Supramaniam R,Smith D,Coates M,Hayes L,Armstrong BK.Breast cancer survival in NSW in 1973 to 1995. Sydney: Cancer Epidemiology Research Unit and NSW Central Cancer Registry Cancer Control Information Centre, NSW Cancer Council, 1998.
  • 9
    Australian Institute of Health and Welfare (AIHW), Australasian Association of Cancer Registries (AACR). Cancer survival in Australia 1992–1997: geographic categories and socioeconomic status. Report No.: 22. Canberra: Australian Institute of Health and Welfare, 2003.
  • 10
    CONCORD Steering Committee. Cancer survival in Europe and North America: the CONCORD study protocol. London School of Hygiene & Tropical Medicine. Accessed on January 10, 2001. Available at: http://www.lshtm.ac.uk/ncdeu/cancersurvival/concord/index.htm.
  • 11
    Woods LM,Rachet B,Coleman MP. Choice of geographic unit influences socioeconomic inequalities in breast cancer survival. Br J Cancer 2005; 92: 127982.
  • 12
    Berkson J,Gage RP. Calculation of survival rates for cancer. Proc Staff Meet Mayo Clin 1950; 25: 27086.
  • 13
    Ederer F,Axtell LM,Cutler SJ. The relative survival: a statistical methodology. Natl Cancer Inst Monogr 1961; 6: 10121.
  • 14
    Ewbank DC,Gomez de Leon JC,Stoto MA. A reducible four-parameter system of model life tables. Popul Stud 1983; 37: 10527.
  • 15
    Coleman MP,Babb P,Mayer D,Quinn MJ,Sloggett A. Cancer survival trends in England and Wales 1971–1995: deprivation and NHS region (CDROM). London: Office for National Statistics, 1999.
  • 16
    Estève J,Benhamou E,Croasdale M,Raymond L. Relative survival and the estimation of net survival: elements for further discussion. Stat Med 1990; 9: 52938.
  • 17
    CRUK Cancer Survival Group. strel computer program version 5.8 and life tables for cancer survival analysis. Non-communicable Disease Epidemiology Unit, London School of Hygiene & Tropical Medicine, UK. Accessed on November 19, 2006. Available at: www.lshtm.ac.uk/ncdeu/cancersurvival/tools.htm.
  • 18
    Brenner H,Gefeller O. Deriving more up-to-date estimates of long-term patient survival. J Clin Epidemiol 1997; 50: 2116.
  • 19
    Grizzle JE,Starmer CF,Koch GG. Analysis of categorical data by linear models. Biometrics 1969; 25: 489504.
  • 20
    Dickman PW,Sloggett A,Hills M,Hakulinen T. Regression models for relative survival. Stat Med 2004; 23: 5164.
  • 21
    Rubin DB. Multiple imputation for non-response in surveys. New York: Wiley, 1987.
  • 22
    Little RL,Rubin DB. Statistical analysis with missing data. New York: Wiley, 1987.
  • 23
    Schafer JL. Analysis of incomplete multivariate data. New York: Chapman & Hall/CRC, 1997.
  • 24
    Collins LM,Schafer JL,Kam CM. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychol Methods 2001; 6: 33051.
  • 25
    Quinn MJ,Martinez-Garcia C,Berrino F,EUROCARE Working Group. Variations in survival from breast cancer in Europe by age and country, 1978–1989. Eur J Cancer 1998; 34: 220411.
  • 26
    Sant M,Capocaccia R,Verdecchia A,Estève J,Gatta G,Micheli A,Coleman MP,Berrino F. Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country.The EUROCARE Working Group. Int J Cancer 1998; 77: 67983.
  • 27
    Vercelli M,Capocaccia R,Quaglia A,Casella C,Puppo A,Coebergh JW,The EUROCARE Working Group. Relative survival in elderly European cancer patients: evidence for health care inequalities. Crit Rev Oncol Hematol 2000; 35: 16179.
  • 28
    Vercelli M,Quaglia A,Casella C,Parodi S,Capocaccia R,Martinez-Garcia C,The EUROCARE Working Group. Relative survival in elderly cancer patients in Europe. Eur J Cancer 1998; 34: 226470.
  • 29
    Sant M,Allemani C,Capocaccia R,Hakulinen T,Aareleid T,Coebergh JW,Coleman MP,Grosclaude P,Martinez C,Bell J,Youngson J,Berrino F. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003; 106: 41622.
  • 30
    Christensen LH,Engholm G,Ceberg J,Hein S,Perfekt R,Tange UB,Andersson M,Mouridsen HT,Moller T,Storm HH. Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables?—a population-based study. Eur J Cancer 2004; 40: 123343.
  • 31
    Jensen AR,Garne JP,Storm HH,Ewertz M,Cold S,Alvegaard T,Overgaard J. Stage and survival in breast cancer patients in screened and non-screened Danish and Swedish populations. Acta Oncol 2003; 42: 7019.
  • 32
    Karjalainen S,Aareleid T,Hakulinen T,Pukkala E,Rahu M,Tekkel M. Survival of female breast cancer patients in Finland and in Estonia: stage at diagnosis an important determinant of the difference between countries. Soc Sci Med 1989; 28: 2338.
  • 33
    Kliukiene J,Andersen A. Survival of breast cancer patients in Lithuania and Norway, 1988–1992. Eur J Cancer 1998; 34: 3727.
  • 34
    Aareleid T,Staneczek W,Rahu M,Mohner M. On the background of differences in survival of female breast cancer patients in the German Democratic Republic and the Estonian SSR. Neoplasma 1990; 37: 58794.
  • 35
    Sant M,Allemani C,Berrino F,Coleman MP,Aareleid T,Chaplain G,Coebergh JW,Colonna M,Crosignani P,Danzon A,Federico M,Gafa L, et al. Breast carcinoma survival in Europe and the United States: a population based study. Cancer 2004; 100: 71522.
  • 36
    Australian Bureau of Statistics. Migration, Australia 2004–2005. Report No.: Cat. no. 3412.0. Canberra: 2006.
  • 37
    Neighbourhood Renewal Unit—Office for the Deputy Prime Minister. The English indices of deprivation 2004 (revised). London: Neighbourhood Renewal Unit, Office for the Deputy Prime Minister, 2004.
  • 38
    Australian Bureau of Statistics. Socio-economic indexes for areas: Australia. Technical report. Report No.: 2039.0.55.001. Canberra: 2004.
  • 39
    Australian Bureau of Statistics. Table 49: expectation of life at single ages (0–100), females, Australia, 1881 onwards. Report No.: 3105.0. 65.001. 2004.
  • 40
    Interim life tables. Government Actuary's Department 1991. Accessed on July 8, 2008. Available at: http://www.gad.gov.uk.
  • 41
    Feinstein AR,Sosin DM,Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312: 16048.
  • 42
    Greenwald HP,Polissar NL,Borgatta EF,McCorkle R,Goodman G. Social factors, treatment, and survival in early-stage non-small cell lung cancer. Am J Public Health 1998; 88: 16814.
  • 43
    Rabeneck L,Souchek J,El Serag HB. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. Am J Gastroenterol 2003; 98: 118692.
    Direct Link:
  • 44
    Farley JH,Hines JF,Taylor RR,Carlson JW,Parker MF,Kost ER,Rogers SJ,Harrison TA,Macri CI,Parham GP. Equal care ensures equal survival for African-American women with cervical carcinoma. Cancer 2001; 91: 86973.
  • 45
    McCollum AD,Catalano PJ,Haller DG,Mayer RJ,Macdonald JS,Benson AB,III,Fuchs CS. Outcomes and toxicity in African-American and Caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer. J Natl Cancer Inst 2002; 94: 11607.
  • 46
    Brawley OW,Freeman HP. Race and outcomes: is this the end of the beginning for minority health research? J Natl Cancer Inst 1999; 91: 19089.
  • 47
    Lavelle K,Todd C,Moran A,Howell A,Bundred N,Campbell M. Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years. Br J Cancer 2007; 96: 1197203.
  • 48
    Ramesh HAJ,Pope D,Gennari R,Audisio RA. Optimising surgical management of elderly cancer patients. World J Surg Oncol 2005; 3: 17.
  • 49
    Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 1687717.
  • 50
    Prout GR,Wesley MN,McCarron PG,Chen VW,Greenberg RS,Mayberry RM,Edwards BK. Survival experience of black patients and white patients with bladder carcinoma. Cancer 2004; 100: 62130.
  • 51
    Polednak AP. Poverty, comorbidity, and survival of colorectal cancer patients diagnosed in Connecticut. J Health Care Poor Underserved 2001; 12: 30210.
  • 52
    Munro AJ,Bentley AHM. Deprivation, comorbidity and survival in a cohort of patients with colorectal cancer. Eur J Cancer Care 2004; 13: 25462.